ArticleNPJ Parkinson's disease2025
Prediction of all-cause mortality in Parkinson's disease with explainable artificial intelligence using administrative healthcare data.
Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A multimodal explainable artificial intelligence framework for interpretable Parkinson's disease prediction.Scientific reports · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
Abstract
Many studies have reported increased mortality risk in patients with Parkinson's disease (PD), but few have investigated the risk factors for PD mortality, including medical and socioeconomic factors. We applied an explainable artificial intelligence (XAI) model to predict long-term all-cause mortality in patients with PD using administrative healthcare data collected at PD diagnosis. Among seven machine learning algorithms, XGBoost achieved the best performance (10-year area under the receiver operating characteristic curve (AUROC): 0.836; 5-year AUROC: 0.894). The most important contributing feature to PD mortality was age, followed by male sex and pneumonia. Using XAI models, the nonlinear association between contributing factors and PD mortality was assessed, and an optimal target value to reduce mortality was found. In addition, prediction of individualized 10-year mortality risk for each PD participant was possible. Our XAI modeling pipeline demonstrated the feasibility to predict long-term mortality in patients with PD using preexisting healthcare data.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.